First Time Loading...
C

Codex DNA Inc
NASDAQ:DNAY

Watchlist Manager
Codex DNA Inc
NASDAQ:DNAY
Watchlist
Price: 2 USD 8.11% Market Closed
Updated: May 4, 2024
Section:
 

Wall Street
Price Targets

DNAY Price Targets Summary
Codex DNA Inc

There are no price targets for DNAY.
DNAY Lowest Forecast
Wall Street Target
Not Available
DNAY Average Forecast
Wall Street Target
Not Available
DNAY Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Codex DNA Inc Competitors:
Price Targets
BROOKS
Brooks Laboratories Ltd
48% Downside
O
OABI
OmniAb Inc
118% Upside
M
300463
Maccura Biotechnology Co Ltd
44% Upside
TMO
Thermo Fisher Scientific Inc
10% Upside
BROOKS
Brooks Laboratories Ltd
48% Downside
O
OABI
OmniAb Inc
118% Upside
M
300463
Maccura Biotechnology Co Ltd
44% Upside
TMO
Thermo Fisher Scientific Inc
10% Upside
QGEN
Qiagen NV
21% Upside
AVTR
Avantor Inc
12% Upside
S
237690
ST Pharm Co Ltd
14% Upside
4133
Abnova Taiwan Corp
225% Upside

Revenue
Forecast

Revenue Estimate
Codex DNA Inc

For the last 1 year the compound annual growth rate for Codex DNA Inc's revenue is 148%. The projected CAGR for the next 1 year is 68%.

148%
Past Growth
68%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Codex DNA Inc

Operating Income forecast
is not available for
Codex DNA Inc

Net Income
Forecast

Net Income Estimate
Codex DNA Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

See Also

Summary
DNAY intrinsic value, competitors valuation, and company profile.
DCF Valuation
DNAY stock valuation using Discount Cash Flow valuation method.
Relative Valuation
DNAY stock valuation using valuation multiples.
Wall Street Estimates
DNAY price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
DNAY stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is DNAY's stock price target?
Not Available

DNAY doesn't have any price targets made by Wall Street professionals.

What is Codex DNA Inc's Revenue forecast?
Projected CAGR
68%

For the last 1 year the compound annual growth rate for Codex DNA Inc's revenue is 148%. The projected CAGR for the next 1 year is 68%.

ALPHA SPREAD
Join more than 134,100+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.